NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Acutaas Chemicals Q3 FY26 PAT Jumps 133.7% to ₹106.2 Cr; Revenue Guidance Raised to 30%
Acutaas Chemicals reported a stellar Q3 FY26 with revenue growing 43% YoY to ₹393.2 crores, driven by a 47% surge in the Advanced Pharma Intermediates segment. The company achieved its highest-ever margins, with EBITDA margins expanding significantly to 38.3% due to a favorable product mix and operating leverage. Management has upgraded its full-year FY26 revenue growth guidance to 30% and EBITDA margin guidance to a range of 32-35%. Strategic expansions into battery and semiconductor chemicals are progressing, with a new battery chemicals block inaugurated in January 2026.
முக்கிய அம்சங்கள்
Revenue from operations grew 43% YoY to ₹393.2 crores in Q3 FY26.PAT crossed the ₹100 crore milestone, reaching ₹106.2 crores, a 133.7% YoY increase.EBITDA margins expanded by 1,335 bps YoY to 38.3%, leading to an upgraded annual margin guidance of 32-35%.Pharma Intermediates segment revenue rose 47% YoY to ₹351.1 crores, fueled by CDMO growth.Inaugurated a new battery chemicals block at Jhagadia; commercial operations expected to ramp up from Q1 FY27.
👀 கவனிக்க வேண்டியவை
Investors should view the guidance upgrade and margin expansion as strong indicators of structural growth and improved product mix. The entry into high-growth battery and semiconductor chemical segments provides a long-term catalyst for valuation re-rating.
Acutaas Chemicals Reports FY25 Revenue of ₹9,898 Million and 25% Capacity Expansion
Acutaas Chemicals Limited, formerly known as Ami Organics, has released its Annual Sustainability Report for FY 2024-25, reporting a standalone revenue of ₹9,898 million. The company achieved a significant 25% increase in production capacity, primarily driven by its Ankleshwar facility. Strategically, the firm is expanding into high-value sectors including semiconductor-grade chemistries and battery materials. On the ESG front, it earned the EcoVadis Platinum Medal, placing it in the top 1% of companies globally, and operationalized 15.8 MW of solar capacity.
முக்கிய அம்சங்கள்
Standalone revenue reached ₹9,898 million with consolidated revenue surpassing ₹1,000 croreProduction capacity increased by 25% during the fiscal year, led by the Ankleshwar unitAchieved EcoVadis Platinum Medal and operationalized 15.8 MW of solar power capacityPortfolio expanded to over 610 chemistries with exports to more than 55 countriesZero conflict-of-interest cases and zero POSH complaints reported for the year
👀 கவனிக்க வேண்டியவை
Investors should note the company's successful transition to its new identity and its strong ESG positioning which may attract institutional capital. The 25% capacity expansion and move into semiconductor chemicals provide a positive outlook for medium-term growth.
Acutaas Chemicals Q3 FY26 Net Profit Surges 139% YoY to ₹108.6 Cr; Revenue Up 42%
Acutaas Chemicals (formerly Ami Organics) reported a stellar performance for Q3 FY26, with consolidated revenue growing 42.3% YoY to ₹391.2 crore. Net profit for the quarter witnessed a massive jump of 139% YoY, reaching ₹108.6 crore compared to ₹45.4 crore in the previous year. For the nine-month period, the company has already surpassed its full-year FY25 profit, recording ₹222.1 crore. The company also highlighted a strategic investment of ₹130.80 crore in its South Korean joint venture, Indichem Inc., to bolster its specialty chemicals portfolio.
முக்கிய அம்சங்கள்
Consolidated Revenue from operations rose 42.3% YoY to ₹39,118.33 Lakhs in Q3 FY26.Net Profit surged by 139% YoY to ₹10,863.62 Lakhs, driven by strong operational efficiency.Basic EPS for the quarter stood at ₹13.12, up from ₹5.42 in the corresponding quarter of the previous year.The company invested ₹130.80 crore in South Korean JV Indichem Inc., holding a 75% stake through its subsidiary.9-month consolidated profit reached ₹22,208.56 Lakhs, a 127% increase over the ₹9,770.16 Lakhs recorded in 9M FY25.
👀 கவனிக்க வேண்டியவை
The company is exhibiting robust earnings momentum and successful execution of its global expansion strategy. Investors should maintain a positive outlook while monitoring the integration of the South Korean JV and the impact of the newly granted ESOPs on future employee costs.
Acutaas Chemicals Q3 FY26 PAT Surges 133.7% YoY to ₹1,062 Mn; Revenue Up 43%
Acutaas Chemicals reported a stellar performance for Q3 FY26, with revenue growing 43% YoY to ₹3,932 million. The company achieved a significant milestone as quarterly PAT crossed ₹1,000 million for the first time, reaching ₹1,062 million. Profitability margins saw substantial expansion, with EBITDA margins jumping to 38.3% from 25.0% in the previous year. Management has also raised its full-year revenue growth guidance from 25% to approximately 30%, citing strong momentum in the CDMO business and upcoming verticals like battery and semiconductor chemicals.
முக்கிய அம்சங்கள்
Revenue from operations grew 43% YoY to ₹3,932 million, driven by the CDMO business ramp-up.Net Profit (PAT) skyrocketed by 133.7% YoY to ₹1,062 million, crossing the ₹1,000 million quarterly milestone.EBITDA margins expanded significantly by 1,330 bps YoY to reach 38.3% compared to 25.0% in Q3FY25.Full-year revenue growth guidance revised upward from 25% to approximately 30% for FY26.Gross margins improved to 57.0%, up 1,073 bps YoY, reflecting a superior product mix and operational efficiency.
👀 கவனிக்க வேண்டியவை
Investors should take note of the significant margin expansion and the management's confidence reflected in the upward guidance revision. The company's strategic pivot into semiconductor and battery chemicals offers strong long-term growth catalysts beyond its core pharmaceutical business.
Acutaas Chemicals Limited, formerly known as Ami Organics Limited, has submitted its standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The independent auditor, Maheshwari & Co., has issued a clean review report, indicating no material misstatements in the financial statements. The consolidated results encompass various subsidiaries including Acutaas Chemicals Electrolytes and Acutaas Advance Material, as well as joint ventures. This filing confirms the company's adherence to SEBI's regulatory reporting requirements.
முக்கிய அம்சங்கள்
Acutaas Chemicals (formerly Ami Organics) filed financial results for the period ended December 31, 2025.Independent Auditor Maheshwari & Co. issued an unmodified review report for both standalone and consolidated financials.The consolidated entity includes subsidiaries such as Baba Fine Chemicals and step-down subsidiaries like Indichem Inc.Financial statements were prepared in accordance with Ind AS 34 (Interim Financial Reporting) and SEBI Regulation 33.The board meeting for the approval of these results was concluded on January 28, 2026.
👀 கவனிக்க வேண்டியவை
Investors should review the detailed profit and loss statements once fully published to assess revenue and margin performance. The clean audit report provides confidence in the company's financial reporting integrity.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Acutaas Chemicals Limited has officially inaugurated Phase 1 of its new state-of-the-art manufacturing block at the Unit-III Jhagadia facility in Gujarat. This dedicated facility will focus on producing electrolyte additives and other battery chemicals, marking a significant expansion into the high-growth EV supply chain. The inauguration took place on January 19, 2026, following an initial project intimation in December 2024. This move aligns with the company's strategy to diversify its specialty chemical portfolio into the energy storage sector.
முக்கிய அம்சங்கள்
Inauguration of Phase 1 of a dedicated manufacturing block for electrolyte additives and battery chemicals.The facility is located at the existing Unit-III Jhagadia site at Plot No. 910/1/B, G.I.D.C., Gujarat.The expansion follows through on the company's strategic plan initiated on December 11, 2024.The new block is described as a 'State of the Art' facility targeting the specialized battery materials market.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for long-term growth in the specialty chemicals space. Monitor the ramp-up of production and the subsequent impact on revenue and margins in the upcoming fiscal quarters.
Acutaas Chemicals Credit Rating Reaffirmed at CARE A+/Stable/CARE A1+
CARE Ratings has reaffirmed the credit ratings for Acutaas Chemicals Limited. The long-term/short-term bank facilities are rated CARE A+; Stable / CARE A1+. The total amount of facilities rated is ₹135.00 crore, enhanced from ₹125 crore. This reaffirmation indicates CARE's continued confidence in Acutaas Chemicals' ability to meet its financial obligations.
முக்கிய அம்சங்கள்
Long Term / Short Term Bank Facilities rated CARE A+; Stable / CARE A1+Total facilities rated amount to ₹135.00 croreFacilities enhanced from ₹125 croreRating reaffirmed by CARE Ratings Limited
👀 கவனிக்க வேண்டியவை
The reaffirmation of credit ratings suggests stability in the company's financial position. Investors should monitor the company's performance and any further rating updates from CARE Ratings.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
